Follow
Guillermo A. Ortiz, MD
Guillermo A. Ortiz, MD
Digestive Diseases, Yale School of Medicine
Verified email at yale.edu - Homepage
Title
Cited by
Cited by
Year
24,25-Dihydroxyvitamin D3 and Vitamin D Status of Community-Dwelling Black and White Americans
AH Berg, CE Powe, MK Evans, J Wenger, G Ortiz, AB Zonderman, ...
Clinical chemistry 61 (6), 877-884, 2015
1172015
Prognosis of acute kidney injury and hepatorenal syndrome in patients with cirrhosis: a prospective cohort study
AS Allegretti, G Ortiz, J Wenger, JJ Deferio, J Wibecan, S Kalim, H Tamez, ...
International journal of nephrology 2015, 2015
1112015
Effect of sofosbuvir-based hepatitis C virus therapy on kidney function in patients with CKD
ME Sise, E Backman, GA Ortiz, GL Hundemer, NN Ufere, DF Chute, ...
Clinical Journal of the American Society of Nephrology 12 (10), 1615-1623, 2017
772017
Changes in kidney function after transjugular intrahepatic portosystemic shunts versus large-volume paracentesis in cirrhosis: a matched cohort analysis
AS Allegretti, G Ortiz, J Cui, J Wenger, I Bhan, RT Chung, RI Thadhani, ...
American Journal of Kidney Diseases 68 (3), 381-391, 2016
602016
Serum angiopoietin‐2 predicts mortality and kidney outcomes in decompensated cirrhosis
AS Allegretti, X Vela Parada, GA Ortiz, J Long, S Krinsky, S Zhao, ...
Hepatology 69 (2), 729-741, 2019
372019
The effects of parenteral amino acid therapy on protein carbamylation in maintenance hemodialysis patients
S Kalim, G Ortiz, CA Trottier, JJ Deferio, SA Karumanchi, RI Thadhani, ...
Journal of Renal Nutrition 25 (4), 388-392, 2015
352015
Cross-sectional examination of metabolites and metabolic phenotypes in uremia
S Kalim, CB Clish, JJ Deferio, G Ortiz, AS Moffet, RE Gerszten, ...
BMC nephrology 16, 1-13, 2015
182015
Siglec-7 as a novel biomarker to predict mortality in decompensated cirrhosis and acute kidney injury
AS Allegretti, G Ortiz, S Kalim, J Wibecan, D Zhang, HY Shan, D Xu, ...
Digestive diseases and sciences 61, 3609-3620, 2016
122016
Pharmacokinetics and drug interactions of medications used to treat hepatitis C virus infection in the setting of chronic kidney disease and kidney transplantation
GA Ortiz, HD Trivedi, C Nader
Hemodialysis International 22, S22-S35, 2018
92018
Effect of short procedural duration with bivalirudin on increased risk of acute stent thrombosis in patients with STEMI: A secondary analysis of the HORIZONS-AMI randomized …
H Tamez, DS Pinto, AJ Kirtane, C Litherland, RW Yeh, GD Dangas, ...
JAMA cardiology 2 (6), 673-677, 2017
62017
Future Pharmacological Therapies of Portal Hypertension
GA Ortiz, G Garcia-Tsao
Current hepatology reports 18, 36-48, 2019
12019
Su1696 SPLEEN STIFFNESS MEASUREMENTS (SSM) IN THE IDENTIFICATION OF CLINICALLY-SIGNIFICANT PORTAL HYPERTENSION (CSPH) IN PATIENTS WITH COMPENSATED CIRRHOSIS.
GA Ortiz, C Palumbo, MW Sayyar, M Balakrishnan, A Mohanty, ...
Gastroenterology 158 (6), S-1385, 2020
2020
Author response to Letter to the Editor:'Dynamics of platelet count after sustained virologic response do not mirror those of hepatic venous pressure gradient'.
GA Ortiz, M Sayyar, G Garcia‐Tsao
Liver International 40 (4), 2020
2020
CAN NON-INVASIVE TESTS (NIT) DETECT CHANGES IN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) IN PATIENTS WITH HEPATITIS C (HCV) COMPENSATED CIRRHOSIS?
G Ortiz, A Mohanty, M Sayyar, P Jangouk, G Gunabushanam, C Sheldon, ...
HEPATOLOGY 70, 1237A-1237A, 2019
2019
A selection of interesting papers that were published in the month before our press date in major journals likely to report important results in gastroenterology and hepatology …
AS Allegretti, X Vela Parada, GA Ortiz, J Long, S Krinsky, S Zhao, ...
Hepatology 69, 729-741, 2019
2019
Adverse events (AE) and laboratory changes in a real-world population of Hepatitis C Virus (HCV)-infected patients with chronic kidney disease (CKD) treated with sofosbuvir …
MD Guillermo Ortiz, MD Gregory Hundemer, MD Nneka Ufere, ...
Hypertension 6, 1.8, 0
The system can't perform the operation now. Try again later.
Articles 1–16